Efficacy of Shenkang Injection combined with renin-angiotensin-aldosterone system blockers in diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
Objective Shenkang injection (SKI), a Traditional Chinese Medicine formulation, is widely used in China for diabetic nephropathy (DN). This systematic review and meta-analysis aimed to evaluate the efficacy and safety of SKI combined with renin-angiotensin-aldosterone system (RAAS) blockers in patie...
| Published in: | Renal Failure |
|---|---|
| Main Authors: | Xinyue Zhang, Xuyuan Lao, Shengchun Liao, Chaoyang Ye, Chen Wang |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2499231 |
Similar Items
Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)
by: Katy Satué, et al.
Published: (2017-06-01)
Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
by: Nestor Vazquez-Agra, et al.
Published: (2023-03-01)
by: Nestor Vazquez-Agra, et al.
Published: (2023-03-01)
Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
by: Ioanna Koniari, et al.
Published: (2023-04-01)
by: Ioanna Koniari, et al.
Published: (2023-04-01)
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
by: Agnese Valentini, et al.
Published: (2025-08-01)
by: Agnese Valentini, et al.
Published: (2025-08-01)
Assessment of Parathyroid Hormone, Vitamin D, Calcium, and Renin-angiotensin-aldosterone System in Nigerians With Hypertension
by: Oloruntoba Ayodele Ekun, et al.
Published: (2024-08-01)
by: Oloruntoba Ayodele Ekun, et al.
Published: (2024-08-01)
View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)
Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis
by: Yu-qiong Lin, et al.
Published: (2024-12-01)
by: Yu-qiong Lin, et al.
Published: (2024-12-01)
Beyond the circulating renin angiotensin aldosterone system
by: Walmor eDe Mello
Published: (2014-07-01)
by: Walmor eDe Mello
Published: (2014-07-01)
Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
by: Xinwu Huang, et al.
Published: (2017-06-01)
by: Xinwu Huang, et al.
Published: (2017-06-01)
View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)
The evolutionary development of the renin angiotensin aldosterone system and its importance for the survival of the human species
by: Natalia Butt-Hussaim, et al.
Published: (2021-03-01)
by: Natalia Butt-Hussaim, et al.
Published: (2021-03-01)
Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway
by: Yan-Ni Wang, et al.
Published: (2022-08-01)
by: Yan-Ni Wang, et al.
Published: (2022-08-01)
The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)
Limited evidence for the usage of renin–angiotensin–aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence
by: Giuseppe Anzillotti, et al.
Published: (2024-10-01)
by: Giuseppe Anzillotti, et al.
Published: (2024-10-01)
Effects of Interactions among Gene Polymorphisms of the Renin–Angiotensin-Aldosterone System on Hypertension in Turkish People from Southeast Anatolia
by: Arpacı Abdullah, et al.
Published: (2019-04-01)
by: Arpacı Abdullah, et al.
Published: (2019-04-01)
The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)
The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)
Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease
by: Mona A. Abdelrahman, et al.
Published: (2016-09-01)
by: Mona A. Abdelrahman, et al.
Published: (2016-09-01)
Advances in Unraveling the Role of the Renin-Angiotensin-AldosteroneSystem in Osteoporosis Pathogenesis
by: Zige Liu, et al.
Published: (2024-01-01)
by: Zige Liu, et al.
Published: (2024-01-01)
Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)
by: Matthew Miller, et al.
Published: (2022-09-01)
The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)
by: A. N. Shevelok
Published: (2020-12-01)
The Impact of Beta-Blockers and Renin-Angiotensin-Aldosterone System Inhibitors on the Prognosis of Atrial Fibrillation Patients with Chronic Obstructive Pulmonary Disease: A Nation-Wide Registry Study
by: Liang H, et al.
Published: (2025-03-01)
by: Liang H, et al.
Published: (2025-03-01)
Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)
by: Fei Qin, et al.
Published: (2022-01-01)
Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin–angiotensin–aldosterone system on COVID-19 disease
by: Christian M. Zobel, et al.
Published: (2024-01-01)
by: Christian M. Zobel, et al.
Published: (2024-01-01)
Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
by: Yan-Huan Feng, et al.
Published: (2016-01-01)
by: Yan-Huan Feng, et al.
Published: (2016-01-01)
The renin angiotensin aldosterone system and COVID-19
by: Hadeel A. Alsufyani, et al.
Published: (2020-08-01)
by: Hadeel A. Alsufyani, et al.
Published: (2020-08-01)
Systematic Review and Meta-Analysis of Renin–Angiotensin–Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
by: Katsunori Yanai, et al.
Published: (2021-07-01)
by: Katsunori Yanai, et al.
Published: (2021-07-01)
Preoperative long-term use of renin-angiotensin-aldosterone system blockers increases the risk of acute kidney injury after coronary artery bypass grafting
by: Xiaokang Xu, et al.
Published: (2025-12-01)
by: Xiaokang Xu, et al.
Published: (2025-12-01)
Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
by: Boris A. Rebrov, et al.
Published: (2023-12-01)
by: Boris A. Rebrov, et al.
Published: (2023-12-01)
Controversy over renin–angiotensin–aldosterone system (RAAS) inhibitors treatment in nephrology and cardiovascular diseases
by: Rafał Ł. Donderski, et al.
Published: (2020-06-01)
by: Rafał Ł. Donderski, et al.
Published: (2020-06-01)
Shenkang injection in the treatment of diabetic nephropathy at stage Ⅲ: A systematic review and meta-analysis
by: WANG Jing-wen, et al.
Published: (2018-01-01)
by: WANG Jing-wen, et al.
Published: (2018-01-01)
Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)
by: O. M. Drapkina, et al.
Published: (2014-07-01)
Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)
by: O. M. Drapkina, et al.
Published: (2014-07-01)
A systematic review of nonsynonymous single nucleotide polymorphisms in the renin–angiotensin–aldosterone system
by: Tomasz Rechciński, et al.
Published: (2022-12-01)
by: Tomasz Rechciński, et al.
Published: (2022-12-01)
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
by: Jordan Loader, et al.
Published: (2022-06-01)
by: Jordan Loader, et al.
Published: (2022-06-01)
Renin-angiotensin-aldosterone system inhibition decreased contrast-associated acute kidney injury in chronic kidney disease patients
by: Yi-Ting Chen, et al.
Published: (2021-01-01)
by: Yi-Ting Chen, et al.
Published: (2021-01-01)
Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
by: Fabrizio Buffolo, et al.
Published: (2021-05-01)
by: Fabrizio Buffolo, et al.
Published: (2021-05-01)
LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)
The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
by: M. Ekholm, et al.
Published: (2021-06-01)
by: M. Ekholm, et al.
Published: (2021-06-01)
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)
by: V. S. Pykhtina, et al.
Published: (2015-09-01)
Similar Items
-
Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01) -
Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
by: Nestor Vazquez-Agra, et al.
Published: (2023-03-01) -
Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
by: Ioanna Koniari, et al.
Published: (2023-04-01) -
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
by: Agnese Valentini, et al.
Published: (2025-08-01) -
Assessment of Parathyroid Hormone, Vitamin D, Calcium, and Renin-angiotensin-aldosterone System in Nigerians With Hypertension
by: Oloruntoba Ayodele Ekun, et al.
Published: (2024-08-01)
